2nd Generation Anti-Psychotic Drugs Publication Bias

According to a study published in PLoS Medicine, trials of second-generation anti-psychotic drugs, i.e. newer forms of medications for the treatment of psychotic illnesses like schizophrenia, that have been published in medical journals, may embellish their apparent clinical effectiveness. This selective reporting of trials is a phenomenon called publication bias...

Source: http://www.medicalnewstoday.com/articles/243196.php

Juan Manuel Fangio Nelson Piquet Stirling Moss Jack Brabham